Abstract:The EGF signaling system plays a major role in the embryo-uterine dialogue during implantation and heparin-binding EGF-like growth factor (HBEGF) serves a role in coordinating embryonic and endometrial development at the site of blastocyst attachment. Implantation in mutant mice lacking HBEGF is delayed, but partially rescued by compensatory upregulation of amphiregulin. As implantation proceeds, HBEGF stimulates trophoblast differentiation and invasive activity essential for placentation. Therefore, we investigated the effects of embryonic HBEGF deficiency on placental development by breeding mice heterozygous for the HBEGF null mutation. Placentas and fetuses were removed on gestation day 14 and weighed. Fetuses were assayed to establish the genotype of corresponding placentas. Placental discs were halved, fixed and embedded in paraffin for sectioning. Central cross sections were deparaffinized for hematoxylin and eosin staining, immunohistochemistry or cell death (TUNEL) assay. Image analysis was used for semiquantification of immunohistochemical staining intensity. Weights of wild type (77.4 ± 3.5 mg; N=12) and heterozygous (76.5 ± 19.3 mg; N=32) placentas were similar, but homozygous null placentas had reduced average weights (59.8 ± 16.0 mg; N=21, p<0.01). Average fetal weight was not significantly affected by genotype. HBEGF immunostaining was gene dose-dependent and differed significantly among the three groups, with heterozygotes having an intermediate level. Other members of the EGF family, amphigreglin, TGF-alpha and EGF were expressed equally in wild type and homozygous null placentas. Histological examination revealed no apparent differences in trophoblast giant cells, but the spongiotrophoblast region was reduced compared to labyrinth in homozygous null placentas. Morphometric assessment of relative area demonstrated that spongiotrophoblast comprised a smaller (p<0.05) proportion of the cross sectional area in null placentas than in the wild type; however, heterozyotes were intermediate and did not differ significantly from the other two genotypes. There were no differences in apoptosis, but proliferation, assessed by nuclear Ki67 staining, was elevated (p<0.05) in the labyrinth and decreased (p<0.05) in the spongiotrophoblast of HBEGF null placentas compared to the wild type. Labyrinth morphology appeared disrupted in HBEGF null placentas stained with laminin to highlight capillary basement membrane. Indeed, the density of laminin-labeled capillaries was decreased (p<0.05) in HBEGF null placentas compared to the wild type, based on morphometric analysis. Immunohistochemical staining revealed reduced vascular endothelial growth factor (VEGF) in both spongiotrophoblast (p=0.06) and labyrinth (p<0.01) regions of HBEGF null placentas, suggesting that poor angiogenesis was due to reduced VEGF. These findings support an active role for HBEGF in placentation. Production of HBEGF by adjacent maternal tissues could have limited the detrimental effects of embryonic HBEGF deficiency. While there was no clear evidence of aberrant giant cell invasion in placentas lacking HBEGF, roles for HBEGF in spongiotrophoblast formation and fetal angiogenesis within the labyrinth were supported. HBEGF could promote fetal capillary formation by inducing VEGF or other angiogenic factors in the developing placenta. Supported by NIH grant HD12304 and the intramural research program of NICHD.

Maternal HBEGF Deficiency Restricts Placentation in Mice.

Maternal Heparin-Binding-Egf Deficiency Limits Pregnancy Success In Mice

Impact of Axis of GHRH and GHRH Receptor on Cell Viability and Apoptosis of the Placental Choriocarcinoma Cell Line.

IGFBP1 Involved in the Decreased Birth Weight Due to Fetal High Estrogen Exposure in Mice

Ggnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and Differentiation.

HMGB1 regulates autophagy of placental trophoblast through ERK signaling pathway

p45NF-E2 represses Gcm1 in trophoblast cells to regulate syncytium formation, placental vascularization and embryonic growth.

The Transcription Factor Nf-E2 Regulates Trophoblast Differentiation and Placental Vascularisation Independent of Platelets

Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse

Effects of excess thromboxane A2 on placental development and nutrient transporters in a Mus musculus model of fetal growth restriction†

Dual Source and Target of Heparin-Binding EGF-like Growth Factor During the Onset of Implantation in the Hamster.

A genetically small fetus impairs placental adaptations near term

Trophoblast-specific Knockdown of CSPG4 Expression Causes Pregnancy Complications with Poor Placentation in Mice

Disruption of the Endothelial Cell Protein C Receptor Gene in Mice Causes Placental Thrombosis and Early Embryonic Lethality*

Junb is Essential for Mammalian Placentation

An activating mutation in the PDGF receptor-beta causes abnormal morphology in the mouse placenta.

A Grhl2-Dependent Gene Network Controls Trophoblast Branching Morphogenesis

Placental growth factor mediates pathological uterine angiogenesis by activating the NFAT5-SGK1 signaling axis in the endometrium: implications for preeclampsia development

Transcriptional Regulator BPTF/FAC1 Is Essential for Trophoblast Differentiation during Early Mouse Development

Aberrant H3K4me3 Modification of Epiblast Genes of Extraembryonic Tissue Causes Placental Defects and Implantation Failure in Mouse IVF Embryos.

MNSF beta regulates placental development by conjugating IGF2BP2 to enhance trophoblast cell invasiveness